INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2020

NAD+ boosting via the precursor niacin shows potential as a treatment strategy for mitochondrial myopathy in humans.

This commentary highlights findings by Pirinen et al. (2020) regarding NAD+ homeostasis in mitochondrial myopathy. The referenced work demonstrates that disruption in NAD+ homeostasis is a key component of the pathogenesis of mitochondrial myopathy in humans. This disruption can be targeted by administering the NAD+ precursor niacin, identifying NAD+ boosting as a potential therapeutic approach.

Study type
Commentary
Who was studied
Mitochondrial myopathy patients
What was measured
Mitochondrial myopathy pathogenesis and NAD+ boosting

THE PAPER

Of Mice and Men: NAD+ Boosting with Niacin Provides Hope for Mitochondrial Myopathy Patients.

Chini EN. Cell Metab, 2020.

PubMed 32492387 ↗DOI 10.1016/j.cmet.2020.05.013 ↗

Nutrients & adequacyOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.